These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36597839)
1. Heart failure related central sympathetic activation: debunking the 'holy grail'? Grassi G Eur J Heart Fail; 2023 Feb; 25(2):211-212. PubMed ID: 36597839 [No Abstract] [Full Text] [Related]
2. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536 [TBL] [Abstract][Full Text] [Related]
3. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554 [TBL] [Abstract][Full Text] [Related]
4. Diffusion weighted imaging: have we found the 'Holy Grail' of diagnostic imaging or is it still a game of numbers? Herneth AM Eur J Radiol; 2003 Mar; 45(3):167-8. PubMed ID: 12595100 [No Abstract] [Full Text] [Related]
5. Sleep apnea in heart failure: implications of sympathetic nervous system activation for disease progression and treatment. Floras JS Curr Heart Fail Rep; 2005 Dec; 2(4):212-7. PubMed ID: 16332315 [TBL] [Abstract][Full Text] [Related]
6. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. Esler M; Kaye D J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571 [TBL] [Abstract][Full Text] [Related]
7. Adrenergic nervous system in heart failure. Esler M; Kaye D; Lambert G; Esler D; Jennings G Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538 [TBL] [Abstract][Full Text] [Related]
8. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Esler M; Kaye D Heart Fail Rev; 2000 Mar; 5(1):17-25. PubMed ID: 16228913 [TBL] [Abstract][Full Text] [Related]
9. Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure. Andersen S; Andersen A; de Man FS; Nielsen-Kudsk JE Eur J Heart Fail; 2015 Apr; 17(4):358-66. PubMed ID: 25704592 [TBL] [Abstract][Full Text] [Related]
10. Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation. Ciarka A; van de Borne P; Pathak A Expert Opin Investig Drugs; 2008 Sep; 17(9):1315-30. PubMed ID: 18694365 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure. Zucker IH; Liu JL Heart Fail Rev; 2000 Mar; 5(1):27-43. PubMed ID: 16228914 [TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. Floras JS J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):72A-84A. PubMed ID: 8376699 [TBL] [Abstract][Full Text] [Related]
13. Sympathetic neuronal regulation of the heart in aging and heart failure. Kaye D; Esler M Cardiovasc Res; 2005 May; 66(2):256-64. PubMed ID: 15820194 [TBL] [Abstract][Full Text] [Related]